Effect of an intensive 3-day social cognitive treatment (can do treatment) on control self-efficacy in patients with relapsing remitting multiple sclerosis and low disability: A single-centre randomized controlled trial.
In patients with chronic disorders, control self-efficacy is the confidence with managing symptoms and coping with the demands of illness. Can do treatment (CDT) is an intensive, 3-day, social cognitive theory-based, multidisciplinary treatment that focuses on identification of stressors, goal setti...
Main Authors: | Peter Joseph Jongen, Ghislaine A van Mastrigt, Marco Heerings, Leo H Visser, Rob P Ruimschotel, Astrid Hussaarts, Lotte Duyverman, Joyce Valkenburg-Vissers, Job Cornelissen, Michel Bos, Maarten van Droffelaar, Rogier Donders |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0223482 |
Similar Items
-
Improved health-related quality of life, participation, and autonomy in patients with treatment-resistant chronic pain after an intensive social cognitive intervention with the participation of support partners
by: Jongen PJ, et al.
Published: (2017-12-01) -
Perspectives and experiences of Dutch multiple sclerosis patients and multiple sclerosis-specialized neurologists on injectable disease-modifying treatment
by: Visser LH, et al.
Published: (2016-04-01) -
Work Participation and Executive Abilities in Patients with Relapsing-Remitting Multiple Sclerosis.
by: Karin van der Hiele, et al.
Published: (2015-01-01) -
Adherence to monthly online self-assessments for short-term monitoring: a 1-year study in relapsing-remitting multiple sclerosis patients after start of disease modifying treatment
by: Jongen PJ, et al.
Published: (2013-04-01) -
Advances in the treatment of relapsing - Remitting multiple sclerosis
by: Radu Tanasescu, et al.
Published: (2014-04-01)